MODELING CHANGE IN SEXUAL FUNCTION FOR MEN ENROLLED ON THE PROSTATE CANCER PREVENTION TRIAL (PCPT)

被引：0
|
作者：
Moinpour, Carol M. [1 ]
Darke, Amy K. [1 ]
Donaldson, Gary W. [2 ]
Patrick, Donald L. [3 ]
Ware, John E., Jr. [4 ]
Shumaker, Sally A. [5 ]
Ganz, Patricia A. [6 ]
Thompson, Ian M., Jr. [7 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA
[2] Univ Utah, Anesthesiol, Salt Lake City, UT USA
[3] Univ Washington, Hlth Serv, Seattle, WA 98195 USA
[4] QualityMetric Inc, Lincoln, RI USA
[5] Wake Forest Univ, Bowman Gray Sch Med, Publ Hlth Sci, Winston Salem, NC USA
[6] Univ Calif Los Angeles, Canc Prevent & Control Res, Los Angeles, CA USA
[7] Univ Texas Hlth Sci Ctr San Antonio, Urol, San Antonio, TX 78229 USA
来源：
QUALITY OF LIFE RESEARCH | 2005年 / 14卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
O-5-B02/15
引用
收藏
页码：2010 / 2010
页数：1
相关论文
共 50 条
  • [1] Prostate Cancer Prevention Trial (PCPT) update
    Coltman, CA
    Thompson, IM
    Feigl, P
    EUROPEAN UROLOGY, 1999, 35 (5-6) : 544 - 547
  • [2] Implementation of the prostate cancer prevention trial (PCPT)
    Goodman, PJ
    Tangen, CM
    Crowley, JJ
    Carlin, SM
    Ryan, A
    Coltman, CA
    Ford, LG
    Thompson, IM
    CONTROLLED CLINICAL TRIALS, 2004, 25 (02): : 203 - 222
  • [3] Longitudinal analysis of sexual function reported by men in the prostate cancer prevention trial
    Moinpour, Carol M.
    Darke, Amy K.
    Donaldson, Gary W.
    Thompson, Ian M., Jr.
    Langley, Connie
    Ankerst, Donna Pauler
    Patrick, Donald L.
    Ware, John E.
    Ganz, Patricia A.
    Shumaker, Sally A.
    Lippman, Scott M.
    Coltman, Charles A., Jr.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (13): : 1025 - 1035
  • [4] DESIGN OF THE PROSTATE-CANCER PREVENTION TRIAL (PCPT)
    FEIGL, P
    BLUMENSTEIN, B
    THOMPSON, I
    CROWLEY, J
    WOLF, M
    KRAMER, BS
    COLTMAN, CA
    BRAWLEY, OW
    FORD, LG
    CONTROLLED CLINICAL TRIALS, 1995, 16 (03): : 150 - 163
  • [5] Prevention of Prostate Cancer Long-Term Results of Prostate Cancer Prevention Trial (PCPT)
    Michel, M. S.
    Nitschmann, S.
    von Hardenberg, J.
    INTERNIST, 2014, 55 (08): : 981 - 982
  • [6] The prostate cancer prevention trial (PCPT).: Relevance for clinical practice
    Schmitz-Draeger, B. J.
    Fischer, C.
    Bismarck, E.
    Doersam, H. J.
    Luemmen, G.
    UROLOGE, 2007, 46 (10): : 1364 - +
  • [7] Prevention of prostate cancer. Long-term results of the Prostate Cancer Prevention Trial (PCPT) [Prävention des prostatakarzinoms. Langzeitergebnisse des Prostate Cancer Prevention Trial (PCPT)]
    Michel M.S.
    Nitschmann S.
    Von Hardenberg J.
    Der Internist, 2014, 55 (8): : 981 - 982
  • [8] The Prostate Cancer Prevention Trial (PCPT): Relevance for clinical practice [Das "Prostate Cancer Prevention Trial" (PCPT): Die bedeutung für den klinischen alltag]
    Schmitz-Dräger B.J.
    Fischer C.
    Bismarck E.
    Dörsam H.J.
    Lümmen G.
    Der Urologe, 2007, 46 (10): : 1364 - 1370
  • [9] COMPARISON OF THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR AND MAGNETIC RESONANCE IMAGING IN SELECTING MEN FOR PROSTATE BIOPSIES
    Salami, Simpa
    Fakhoury, Mathew
    Ryniker, Laura
    Yaskiv, Oksana
    Turkbey, Baris
    Ben-Levi, Eran
    Villani, Robert
    Vira, Manish
    Rastinehad, Ardeshir
    JOURNAL OF UROLOGY, 2014, 191 (04): : E549 - E549
  • [10] The finasteride prostate cancer prevention trial (PCPT) - What have we learned?
    Mellon, JK
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (13) : 2016 - 2022
12345